Dr Namyong Kim

Namyong Kim brings with him more than 15 years of experiences in scientific research and technical management in the development of biotech instrumentation. He holds more than 10 patents and patent applications, and has published a number of scientific publications in peer-reviewed journals.

Prior to coming to Singapore, Namyong was based in the US where he had the opportunity to work with early-stage high-tech ventures and multinational companies. At BioTrove, he led a chemistry group in the development of the OpenArray^™ platform, a miniaturized chip-based platform for homogeneous biological assays. Earlier to that, he worked with the two-cofounders of Arradial as the Director of Chemistry, and contributed to growing the company into a 15-person team. At Agilent Technologies, he worked on the optimization and commercialization of DNA microarrays as a Research Scientist.

Namyong received his PhD in Chemistry from the Massachusetts Institute of Technology (MIT), and his BSc from the Korea Advanced Institute of Science and Technology (KAIST).

Mr Siah Chong Cheong

SC Cheong brings with him a unique experience and expertise that cover what the multi-nationals are doing right and how a start-up should prioritize to survive well.

SC manages Curiox’s Singapore operation. Formerly, he was the Director for Mdesign Solutions Pte Ltd, a full turnkey design consultant that supports a company in commercializing its propriety technology. Prior to MDesign, he worked in Philips Electronics for 15 years holding various key positions in project management, design, people management, product costing, and financial controlling at various countries. He also managed a precision molding business as Executive Director.

SC received a Master in Business Administration specialized in International Business from Nanyang Technological University (NTU) and an honors degree for Engineering from National University of Singapore (NUS).

Mr Giok Lak Sim

Mr Sim is qualified as an accountant in 1967. He is Fellow of the Australian Society of Certified Practising Accountants and Fellow of the Institute of Certified Public Accountants, Singapore.

Mr Sim is a founder of Zicom Holdings Pte Ltd in 1978 and was appointed to the board on 5 April 1995. He has been Chairman and Managing Director of Zicom Group Limited and Executive Chairman of all subsidiaries. He is a true entrepreneur and savvy business executive with expertise in public accounting, corporate development, financial and industrial management and international trade.

Mr Sim also holds the position of a Chairman of BioBot Surgical Pte Ltd, a surgical robotic company and a director of HistoIndex Pte Ltd, a company involved in the development of histology indexing. He is the recipient of the Ernest & Young Entrepreneur of the Year (Industrial Products) 2008 award in Singapore.

Dr Alex Matter

Dr Matter is best known for his contribution to the development of Glivec/ Gleevec, one of the world’s first tyrosine kinase inhibitor drugs for cancer therapy. He led a team of around 200 scientists at Novartis to discover and optimize the lead compound, bringing it all the way through its first clinical trial in 1998. In a short span of 3 years, Gleevec was given a rare, fast track FDA approval in 2001.

Prior to ETC, Dr Matter was the founding director for the Novartis Institute for Tropical Diseases (NITD) in 2003. Under his leadership, NITD successfully implemented research programs in the areas of dengue fever, tuberculosis and malaria attracting major grants from the Bill&Melinda Gates Foundation and the Wellcome Trust.

A medical doctor by training, Dr. Matter received his medical degree from the University of Basel and did immunology and pathology research in Switzerland, Britain, France and the US before entering into the pharmaceutical industry. He has published more than 100 scientific articles plus several book chapters in the area of oncology and hematology. He is the recipient of the 13th Warren-Alpert prize and the AACR-Bruce F. Cain Memorial Award.

Mr Kok Hwee Sim

Mr Sim is Executive director of ZGL and director of various group’s subsidiaries. He has a range of experiences in and is responsible for group corporate development, restructuring, business valuations and acquisitions.

Mr Sim received his Master of Financial Engineering degree from Columbia University and Bachelor of Industrial and Operations Engineering (Magna Cum Laude) degree from the University of Michigan.

Dr Namyong Kim

Namyong Kim brings with him more than 15 years of experiences in scientific research and technical management in the development of biotech instrumentation. He holds more than 10 patents and patent applications, and has published a number of scientific publications in peer-reviewed journals.

Prior to coming to Singapore, Namyong was based in the US where he had the opportunity to work with early-stage high-tech ventures and multinational companies. At BioTrove, he led a chemistry group in the development of the OpenArray^™ platform, a miniaturized chip-based platform for homogeneous biological assays. Earlier to that, he worked with the two-cofounders of Arradial as the Director of Chemistry, and contributed to growing the company into a 15-person team. At Agilent Technologies, he worked on the optimization and commercialization of DNA microarrays as a Research Scientist.

Namyong received his PhD in Chemistry from the Massachusetts Institute of Technology (MIT), and his BSc from the Korea Advanced Institute of Science and Technology (KAIST).

Mr Siah Chong Cheong

SC Cheong brings with him a unique experience and expertise that cover what the multi-nationals are doing right and how a start-up should prioritize to survive well.

SC manages Curiox’s Singapore operation. Formerly, he was the Director for Mdesign Solutions Pte Ltd, a full turnkey design consultant that supports a company in commercializing its propriety technology. Prior to MDesign, he worked in Philips Electronics for 15 years holding various key positions in project management, design, people management, product costing, and financial controlling at various countries. He also managed a precision molding business as Executive Director.

SC received a Master in Business Administration specialized in International Business from Nanyang Technological University (NTU) and an honors degree for Engineering from National University of Singapore (NUS).